NT
Neeraja Thippabhotla
About Neeraja Thippabhotla
Data last updated:
Neeraja Thippabhotla is an Additional Director at Shangrila Intermediaries Private Limited (since 2015). The companies operate in Pharma and Chemicals. Shangrila Intermediaries Private Limited reported revenue of ₹64,132 (FY 2025). Earlier, Neeraja Thippabhotla was a Partner at Exarmed Pharma Llp (2024) and Director at Cleatus Laboratories Private Limited (2006–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shangrila Intermediaries Private Limited U24239TG2004PTC043270 | Additional Director | 20 Mar 2015 | 2004 | ₹64,132 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Exarmed Pharma Llp ACI-6222 | Partner | 27 Jul 2024 | 2024 | Active | |
| Cleatus Laboratories Private Limited U24232KA2006PTC126499 | Director | 20 Dec 2006 | 2006 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Neeraja Thippabhotla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vikram Bery | 02166843 | Shangrila Intermediaries Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neeraja Thippabhotla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeraja Thippabhotla
Neeraja Thippabhotla currently holds 1 directorship: Shangrila Intermediaries Private Limited (Additional Director, since 20 Mar 2015, revenue ₹64,132 (FY 2025)).
Neeraja Thippabhotla was first appointed on 20 Dec 2006 as Director at Cleatus Laboratories Private Limited. The most recent appointment on record is 27 Jul 2024 at Exarmed Pharma Llp.
Neeraja Thippabhotla held 2 earlier board appointments: Exarmed Pharma Llp (Partner, 27 Jul 2024 to 12 Aug 2024); Cleatus Laboratories Private Limited (Director, 20 Dec 2006 to 16 Aug 2019).
The current boards of Neeraja Thippabhotla's companies include Vikram Bery (Shangrila Intermediaries Private Limited).